NEET-PG 2013 — Internal Medicine
157 Previous Year Questions with Answers & Explanations
Which of the following statements regarding falciparum malaria is false?
Which condition is primarily associated with tetany?
Which of the following is NOT a recommended primary management option for a patient with a snake bite?
Which of the following is used in the treatment of well-differentiated thyroid carcinoma?
Classification of aortic dissection depends on.
What is the primary vascular abnormality associated with intestinal angiodysplasia?
Migraine is due to
Type 3 respiratory failure occurs due to ?
Response to iron therapy in iron deficiency anemia is denoted by?
Which of the following statements about obesity is FALSE?
NEET-PG 2013 - Internal Medicine NEET-PG Practice Questions and MCQs
Question 1: Which of the following statements regarding falciparum malaria is false?
- A. Haemoglobinuria and renal failure
- B. Hypoglycemia
- C. Cerebral malaria
- D. Adequately prevented with chloroquine therapy (Correct Answer)
Explanation: ***Adequately prevented with chloroquine therapy*** - This statement is **false** because many strains of *Plasmodium falciparum* are now **resistant to chloroquine**, making it ineffective for prevention or treatment in most endemic areas [1]. - The widespread **drug resistance** of *P. falciparum* to chloroquine means it is no longer considered an adequate preventative measure. *Haemoglobinuria and renal failure* - These are **true** complications of severe *Falciparum malaria*, often termed **"blackwater fever"**, due to massive **intravascular hemolysis** and subsequent **acute kidney injury** [1]. - Renal failure can result from **hemoglobinuria**, **hypovolemia**, and **acidosis** associated with severe infection. *Hypoglycemia* - **Hypoglycemia** is a **true** and life-threatening complication of severe *Falciparum malaria*, particularly in children, pregnant women, and patients treated with **quinine** [1]. - It occurs due to increased **glucose consumption** by parasites and host cells, impaired **gluconeogenesis**, and drug-induced **insulin secretion**. *Cerebral malaria* - **Cerebral malaria** is a **true**, severe, and often fatal neurological complication of *Falciparum malaria*, characterized by **impaired consciousness** or **coma** [1]. - It is caused by **sequestration** of parasitized red blood cells in the **cerebral microvasculature**, leading to **microcirculatory obstruction** and inflammation.
Question 2: Which condition is primarily associated with tetany?
- A. None of the options
- B. Hyperparathyroidism
- C. Hypercalcemia
- D. Hypocalcemia (Correct Answer)
Explanation: ***Hypocalcemia*** - **Tetany** is a neuromuscular hyperexcitability state resulting from critically low levels of **ionized calcium** in the extracellular fluid [2]. - Reduced extracellular calcium increases neuronal membrane excitability, leading to spontaneous and repetitive nerve discharges and muscle contractions. *Hypercalcemia* - **Hypercalcemia** refers to elevated calcium levels, which *decreases* neuromuscular excitability. - Symptoms typically involve **fatigue, weakness, constipation, and kidney stones**, rather than tetany [1]. *Hyperparathyroidism* - **Primary hyperparathyroidism** is a common cause of **hypercalcemia** due to increased PTH secretion [3]. - Therefore, it leads to symptoms associated with high calcium, not low calcium and tetany. *None of the options* - This option is incorrect because **hypocalcemia** is a well-established cause of tetany.
Question 3: Which of the following is NOT a recommended primary management option for a patient with a snake bite?
- A. Wash with soap and water (Correct Answer)
- B. Reassure the patient
- C. Splinting and immobilization
- D. Keep the site of bite below heart level
Explanation: ***Wash with soap and water*** - Washing the bite with soap and water is **NOT** a recommended primary management option for a snake bite as it can spread the **venom**, potentially worsening the local effects and systemic absorption [1]. - The focus should be on **immobilization and minimizing movement** to restrict venom spread [1], [3]. *Splinting and immobilization* - **Immobilization** of the bitten limb is crucial to reduce venom dissemination through the **lymphatic system** [1], [2]. - This helps to **slow the absorption** of venom into the systemic circulation [1], [3]. *Reassure the patient* - **Anxiety and panic** can increase heart rate and metabolism, potentially accelerating venom absorption. - **Reassurance** helps to calm the patient, which can slow the spread of venom and improve cooperation with treatment [1], [2]. *Keep the site of bite below heart level* - Keeping the affected limb **below heart level** helps to reduce blood flow and, consequently, the systemic spread of venom [1]. - This simple maneuver can **delay the onset** of systemic toxic effects [1].
Question 4: Which of the following is used in the treatment of well-differentiated thyroid carcinoma?
- A. I131 (Correct Answer)
- B. 99m Tc
- C. 32p
- D. MIBG
Explanation: ***I131*** - **Radioactive iodine (I131)** is specifically absorbed by **well-differentiated thyroid cancer cells** because these cells retain the ability to uptake iodine, unlike other types of cancer cells. - Used for **ablating residual thyroid tissue** after surgery and for treating **metastatic well-differentiated thyroid carcinoma** [1]. *99m Tc* - **Technetium-99m (99m Tc)** is primarily used for **diagnostic imaging** (e.g., thyroid scans, bone scans), not for therapeutic treatment of thyroid cancer. - It has a short half-life and emits gamma rays, making it suitable for imaging but generally not for delivering sustained radiation for therapeutic effect. *32p* - **Phosphorus-32 (32p)** is a beta-emitting radionuclide used in the treatment of certain hematological malignancies, such as **polycythemia vera**, and for palliative treatment of bone metastases. - It is not selectively taken up by thyroid cancer cells and therefore is not used in the treatment of thyroid carcinoma. *MIBG* - **Metaiodobenzylguanidine (MIBG)**, often labeled with I123 (diagnostic) or I131 (therapeutic), is used in the diagnosis and treatment of **neuroendocrine tumors** like **pheochromocytoma** and **neuroblastoma**. - Its uptake mechanism targets cells of neuroectodermal origin, which is distinct from the iodine uptake mechanism of thyroid cells.
Question 5: Classification of aortic dissection depends on.
- A. Cause of dissection
- B. Level of aorta affected (Correct Answer)
- C. Extent of symptoms
- D. Percentage of aorta affected
Explanation: The classification of aortic dissection is primarily based on the **segment of the aorta involved**, typically divided into Stanford and DeBakey classifications [1]. This classification helps determine **management strategies** and prognosis based on the affected aortic region (ascending or descending) [1]. Understanding the classification is crucial for guiding **treatment decisions** and predicting outcomes [1]. The classification is more concerned with **anatomical location** rather than the etiology, such as hypertension or collagen disorders [1].
Question 6: What is the primary vascular abnormality associated with intestinal angiodysplasia?
- A. Arteriovenous malformation (Correct Answer)
- B. Capillary hemangioma (usually superficial)
- C. Malignant tumor
- D. Cavernous hemangioma
Explanation: ***AV malformation*** - **Intestinal angiodysplasia** is characterized by abnormal **arteriovenous (AV) connections**, leading to vascular lesions in the gut [1]. - These malformations can cause **chronic gastrointestinal bleeding** due to fragility of the blood vessels [1]. *Capillary hemangioma* - This is a **benign vascular tumor** often found in the skin or subcutaneous tissue, not specifically associated with intestinal vascular changes. - **Capillary hemangiomas** typically do not cause significant gastrointestinal bleeding as seen in angiodysplasia. *Malignant tumor* - Intestinal angiodysplasia is a **benign condition** and not a malignant tumor, therefore it does not fit the characteristics of malignancy. - **Malignant tumors** usually present with different symptoms and underlying pathophysiology than angiodysplasia. *Cavernous hemangioma* - This type of hemangioma involves larger vascular channels and is typically more associated with the liver than the intestines. - **Cavernous hemangiomas** do not relate to the intestinal bleeding patterns seen in angiodysplasia.
Question 7: Migraine is due to
- A. Cortical spreading depression (Correct Answer)
- B. Dilatation of cranial blood vessels
- C. Constriction of cranial blood vessels
- D. Inflammation of the meninges
Explanation: ***Cortical spreading depression*** - The current understanding is that **cortical spreading depression (CSD)** is the initiating event in migraine with aura, characterized by a wave of neuronal and glial depolarization that spreads across the cerebral cortex, leading to a temporary shutdown of neuronal activity [1]. - CSD is thought to activate the **trigeminal nerve**, subsequently causing the release of inflammatory neuropeptides and contributing to the pain phase [1]. *Dilatation of cranial blood vessels* - While **vasodilation of intracranial and extracranial blood vessels** does occur during the headache phase of migraine, it is now considered a *consequence* of the initial neurological events rather than the primary cause [1]. - This vasodilation contributes to the throbbing sensation of migraine pain but does not explain the aura or the initiation of the attack. *Constriction of cranial blood vessels* - **Vasoconstriction** was previously thought to be the cause of the migraine aura, but this theory has largely been disproven. - While some temporary constriction may precede CSD, it is not the primary mechanism behind the migraine attack. *Inflammation of the meninges* - While **neurogenic inflammation** of the meninges, involving the release of inflammatory mediators like **calcitonin gene-related peptide (CGRP)**, does play a role in sensitizing the trigeminal system and contributing to migraine pain, it is a downstream effect. - It is not the initial trigger for a migraine attack but rather part of the pain pathway activated by events like CSD.
Question 8: Type 3 respiratory failure occurs due to ?
- A. Post-operative atelectasis (Correct Answer)
- B. Kyphoscoliosis
- C. Flail chest
- D. Pulmonary fibrosis
Explanation: ***Post-operative atelectasis*** - **Type 3 respiratory failure**, also known as **perioperative respiratory failure**, is characterized by hypoxemia occurring typically after surgery. - **Atelectasis**, the collapse of lung tissue, is a common cause of hypoxemia in the post-operative period due to shallow breathing, pain, and anesthesia affecting lung volumes. *Kyphoscoliosis* - This condition leads to a **restrictive lung disease** due to chest wall deformity, causing chronic respiratory failure. [1] - It more typically results in **Type 2 respiratory failure** (hypercapnic) due to impaired ventilation over time. [1] *Flail chest* - Flail chest is a severe chest wall injury causing paradoxical movement, leading to **acute respiratory failure**. - It is often associated with **Type 1 (hypoxemic)** or **Type 2 (hypercapnic)** respiratory failure due to trauma-induced lung injury and impaired mechanics. *Pulmonary fibrosis* - This is a progressive interstitial lung disease causing **restrictive ventilatory defect** and impaired gas exchange. - It leads to chronic **Type 1 respiratory failure** (hypoxemic) as the lung tissue becomes stiff and scarred.
Question 9: Response to iron therapy in iron deficiency anemia is denoted by?
- A. Increase in hemoglobin
- B. Reticulocytosis (Correct Answer)
- C. Restoration of enzymes
- D. Increase in iron binding capacity
Explanation: Reticulocytosis - Reticulocytosis is one of the earliest signs of a positive response to iron therapy in iron deficiency anemia, occurring within 5-10 days. - It signifies that the bone marrow is effectively producing new red blood cells after iron supplementation. Restoration of enzymes - While iron is a crucial component of many enzymes (e.g., catalase, cytochrome oxidase), its restoration takes time and is not the primary immediate indicator of therapeutic response. - Clinical improvement and other hematological parameters precede the full restoration of enzyme function. Increase in hemoglobin - An increase in hemoglobin is a definitive sign of successful treatment, but it occurs later than reticulocytosis, typically visible after several weeks to months of therapy. - Hemoglobin levels rise as the new, iron-sufficient red blood cells fully mature and replace the older, iron-deficient ones. Increase in iron binding capacity - In iron deficiency anemia, total iron-binding capacity (TIBC) is typically increased due to more transferrin being available to bind iron [1]. - Successful iron therapy would lead to a decrease in TIBC as transferrin sites become saturated with iron, not an increase.
Question 10: Which of the following statements about obesity is FALSE?
- A. There is no genetic predisposition to obesity. (Correct Answer)
- B. Smoking is associated with weight loss
- C. Obesity affects only females.
- D. The prevalence of obesity decreases with age.
Explanation: There is no genetic predisposition to obesity. - This statement is false because genetic factors play a significant role in an individual's susceptibility to obesity, influencing metabolism, appetite, and fat storage [1]. - While environment and lifestyle are crucial, polygenic influences and certain single-gene disorders can heavily predispose individuals to weight gain [1]. *Smoking is associated with weight loss* - Smoking can lead to appetite suppression and an increased metabolic rate, which may result in weight loss or lower body weight compared to non-smokers. - However, this is not a healthy or recommended method for weight control due to the numerous severe health risks associated with smoking. *Obesity affects only females.* - This statement is false; obesity affects both males and females across all age groups and demographics [2]. - Although there can be differences in fat distribution and associated health risks between sexes, obesity is a global health issue impacting everyone [2]. *The prevalence of obesity decreases with age.* - This statement is generally false; the prevalence of obesity tends to increase with age through middle adulthood before possibly leveling off or slightly declining in older age. - Factors like decreased physical activity, changes in metabolism, and chronic disease accumulation contribute to weight gain later in life [3].